Revolutionizing Rare Disease Care
with AI-Driven Insights
At Orsini, we’re committed to enhancing the lives of rare disease patients through innovative technology and personalized care. That’s why we’re proud to introduce ORBIT™ (Orsini Rare Business Intelligence Technology), our advanced artificial intelligence (AI)-enabled reporting and analytics platform.
What is ORBIT?
ORBIT is a cutting-edge platform that leverages AI to provide pharmaceutical manufacturers with actionable insights to inform personalized support for rare disease patients. By integrating real-world data with robust analytics, ORBIT enables:
- Enhanced Patient Engagement: Personalized care strategies tailored to the unique needs of each patient.
- Adherence and Outcomes Support: Insights that help ensure patients stay on track with their treatment.
- Informed Decision-Making: Comprehensive reporting and analytics to support strategic initiatives.
Key Features
- AI-Powered Insights: ORBIT harnesses the latest advancements in AI to analyze and interpret complex data, delivering valuable insights into patient journeys.
- Real-Time Data Integration: Designed with an API-forward approach, ORBIT seamlessly exchanges data with our pharmacy, patient engagement platforms, manufacturers’ systems, and other business associates. For example, learn more about our partnership with PicnicHealth to improve real-world study execution.
- Flexibility and Agility: Built to adapt to the evolving needs of rare disease care, ORBIT supports dynamic data collection and analysis for a holistic view of the patient journey.
Request a Demo
Discover how ORBIT can transform your approach to rare disease care. Request a demo today.